SEC Filings

About Us
Our Medicines
Product Candidates
Investors & Media
Careers
Twitter Linkedin-in Facebook-f
© 2023 Verrica Pharmaceuticals.

BREAKING NEWS:

Verrica announced the approval of YCANTH (cantharidin) topical solution
Learn More
XAxFmrlc

Please see Important Safety Information and full Prescribing Information